198 related articles for article (PubMed ID: 16604093)
1. GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.
Wilson RJ; Giblin GM; Roomans S; Rhodes SA; Cartwright KA; Shield VJ; Brown J; Wise A; Chowdhury J; Pritchard S; Coote J; Noel LS; Kenakin T; Burns-Kurtis CL; Morrison V; Gray DW; Giles H
Br J Pharmacol; 2006 Jun; 148(3):326-39. PubMed ID: 16604093
[TBL] [Abstract][Full Text] [Related]
2. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
Wilson RJ; Giles H
Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
4. A novel inhibitory prostanoid receptor in piglet saphenous vein.
Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
[TBL] [Abstract][Full Text] [Related]
5. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
[TBL] [Abstract][Full Text] [Related]
6. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
Iyú D; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
Platelets; 2010; 21(5):329-42. PubMed ID: 20433310
[TBL] [Abstract][Full Text] [Related]
7. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Lydford SJ; McKechnie KC; Leff P
Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
[TBL] [Abstract][Full Text] [Related]
8. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
9. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
Jones RL; Chan K
Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the agonist activity of prostacyclin analogues on prostanoid EP4 receptors using GW 627368 and taprostene: evidence for species differences.
Jones RL; Chan KM
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):289-99. PubMed ID: 15763441
[TBL] [Abstract][Full Text] [Related]
11. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
[TBL] [Abstract][Full Text] [Related]
12. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
[TBL] [Abstract][Full Text] [Related]
13. Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.
Foudi N; Kotelevets L; Louedec L; Leséche G; Henin D; Chastre E; Norel X
Br J Pharmacol; 2008 Aug; 154(8):1631-9. PubMed ID: 18516068
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
17. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4.
Robertson FM; Simeone AM; Lucci A; McMurray JS; Ghosh S; Cristofanilli M
Cancer; 2010 Jun; 116(11 Suppl):2806-14. PubMed ID: 20503412
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
20. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]